Overview

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD.

Status:
NOT_YET_RECRUITING

Trial end date:
2027-08-31

Target enrollment:

Participant gender:

Summary

To compare the efficacy and safety of the combination of alogliptin and actoplus met with that of actoplus met alone in improving the glucose and lipid metabolism and pancreatic function in T2DM patients complicated with MAFLD.

Phase:

PHASE4

Details

Lead Sponsor:

The Fourth Affiliated Hospital of Zhejiang University School of Medicine